Literature DB >> 10981093

Good news for the older patient with diabetes: added cardiovascular risk reduction.

D G Vidt1.   

Abstract

Both hypertension and diabetes carry an increased risk of cardiovascular and renal disease and are commonly associated conditions. The prevalence of hypertension in the diabetic population is particularly high, approximately 40% in middle-aged patients with type II diabetes mellitus and increases to approximately 60% by age 75. Hypertension increases an already high risk of cardiovascular disease events associated with diabetes mellitus and is also a risk factor for the development of microalbuminuria and retinopathy. Overall mortality from heart disease has declined substantially in the USA in the past 30 years. The extent of this mortality rate decline has been assessed from representative cohorts, the NHANES I survey (1971-1975) and the NHANES I epidemiologic follow-up survey (1982-1984). Both cohorts were followed prospectively for 8 to 9 years. Mortality rates for heart disease and ischemic heart disease in men and women with diabetes have not decreased to the extent that they have for nondiabetic patients. Although these decreases in men with diabetes were smaller than their nondiabetic counterparts, women with diabetes had increases for both total and ischemic heart disease. Three recent clinical trials have addressed the effects of aggressive intervention in diabetes, particularly older patients with type II diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10981093     DOI: 10.1007/s11906-999-0051-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  6 in total

1.  Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.

Authors:  I Gustafsson; C Torp-Pedersen; L Køber; F Gustafsson; P Hildebrandt
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

2.  Diabetes and decline in heart disease mortality in US adults.

Authors:  K Gu; C C Cowie; M I Harris
Journal:  JAMA       Date:  1999-04-14       Impact factor: 56.272

3.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

Review 4.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

Authors:  R Collins; S MacMahon
Journal:  Br Med Bull       Date:  1994-04       Impact factor: 4.291

5.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

6.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12
  6 in total
  1 in total

1.  Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.

Authors:  Manash P Baruah; Sanjay Kalra; Ambika Gopalkrishnan Unnikrishnan; Syed Abbas Raza; Noel Somasundaram; Mathew John; Prasad Katulanda; Dina Shrestha; Ganpathy Bantwal; Rakesh Sahay; Tint Swe Latt; Faruque Pathan
Journal:  Indian J Endocrinol Metab       Date:  2011-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.